PTC Therapeutics
PTCT
119 hedge funds and large institutions have $190M invested in PTC Therapeutics in 2016 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 45 closing their positions.
61% more call options, than puts
Call options by funds: $3.99M | Put options by funds: $2.49M
37% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 35
16% less funds holding
Funds holding: 141 → 119 (-22)
20.19% less ownership
Funds ownership: 105.94% → 85.75% (-20%)
47% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 45
84% less capital invested
Capital invested by funds: $1.18B → $190M (-$985M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$26.6M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$17.9M |
| 3 |
Renaissance Technologies
New York
|
+$16.5M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$12.4M |
| 5 |
Millennium Management
New York
|
+$9.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
-$60.7M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$29.9M |
| 3 |
CCI
Columbus Circle Investors
|
-$28.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$24.9M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$23.4M |
PTCT Hedge Fund Activity: Q1 2016 in Review
119 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q1 2016, worth a combined $190M — down 84% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of PTCT and 24 opened new positions — a net loss of 21 holders — while 35 trimmed existing stakes and 48 added.
The largest buyer was Wellington Management Group, adding an estimated $26.6M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $60.7M sold.
- 119 institutional investors held PTC Therapeutics (PTCT) as of Q1 2016, down from 141 in Q4 2015.
- Funds reported $190M of PTC Therapeutics stock for Q1 2016, down 84% quarter-over-quarter.
- 24 funds opened new PTC Therapeutics positions in Q1 2016 and 45 closed out, a net change of -21 holders.
- The largest PTC Therapeutics buyer in Q1 2016 was Wellington Management Group, an estimated $26.6M added.
- The largest PTC Therapeutics seller in Q1 2016 was Westfield Capital Management, an estimated $60.7M sold.
Based on aggregated 13F filings for Q1 2016.